中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation

文献类型：期刊论文

作者Su, Haixia3,4; Zou, Yi3; Chen, Guofeng3,4; Dou, Huixia3; Xie, Hang3; Yuan, Xiaojing3,4; Zhang, Xianglei3,4; Zhang, Naixia1,4; Li, Minjun2; Xu, Yechun3,4
刊名JOURNAL OF MEDICINAL CHEMISTRY
出版日期2020-04-23
卷号63期号:8页码:4090-4106
ISSN号0022-2623
DOI10.1021/acs.jmedchem.9b02107
通讯作者Xu, Yechun(ycxu@simm.ac.cn)
英文摘要Fatty-acid binding protein 4 (FABP4) is a promising therapeutic target for immunometabolic diseases, while its potential for systemic inflammatory response syndrome treatment has not been explored. Here, a series of 2-(phenylamino)benzoic acids as novel and potent FABP4 inhibitors are rationally designed based on an interesting fragment that adopts multiple binding poses within FABP4. A fusion of these binding poses leads to the design of compound 3 with an similar to 460-fold improvement in binding affinity compared to the initial fragment. A subsequent structure-aided optimization upon 3 results in a promising lead (17) with the highest binding affinity among all the inhibitors, exerting a significant anti-inflammatory effect in cells and effectively attenuating a systemic inflammatory damage in mice. Our work therefore presents a good example of lead compound discovery derived from the multiple binding poses of a fragment and provides a candidate for development of drugs against inflammation-related diseases.
WOS关键词PARTICLE MESH EWALD ; FATTY-ACID ; PROTEIN 4 ; APOLIPOPROTEIN-E ; RECEPTOR ; AP2 ; DRUG ; ATHEROSCLEROSIS ; MACROPHAGES ; EXPRESSION
资助项目National Key R&D Program of China[2016YFA0502301] ; National Natural Science Foundation of China[81661148046] ; National Natural Science Foundation of China[21877122] ; National Natural Science Foundation of China[21807104] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China[2018ZX09711002]
WOS研究方向Pharmacology & Pharmacy
语种英语
出版者AMER CHEMICAL SOC
WOS记录号WOS:000529170200018
源URL[http://119.78.100.183/handle/2S10ELR8/280598]  
专题中国科学院上海药物研究所
通讯作者Xu, Yechun
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai Synchrotron Radiat Facil, Shanghai 201210, Peoples R China
3.Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
推荐引用方式
GB/T 7714		 Su, Haixia,Zou, Yi,Chen, Guofeng,et al. Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation[J]. JOURNAL OF MEDICINAL CHEMISTRY,2020,63(8):4090-4106.
APA Su, Haixia.,Zou, Yi.,Chen, Guofeng.,Dou, Huixia.,Xie, Hang.,...&Xu, Yechun.(2020).Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation.JOURNAL OF MEDICINAL CHEMISTRY,63(8),4090-4106.
MLA Su, Haixia,et al."Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation".JOURNAL OF MEDICINAL CHEMISTRY 63.8(2020):4090-4106.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。